Skip to Content
Merck
  • Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis.

Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis.

Nephron (2020-10-23)
Xiaoyan Wen, Jicheng Zhang, Xiaojian Wan, Alicia A Frank, Xin Qu, John A Kellum
ABSTRACT

Urinary tissue inhibitor of metalloproteinases (TIMP)-2 has been identified as a predictive marker for acute kidney injury (AKI), including sepsis-associated AKI (S-AKI). Whether TIMP-2 might be causally related to AKI and hence represent a viable drug target is unclear. The aim of this study was to evaluate whether suppression of TIMP-2 attenuates S-AKI. Balb/c mice were randomized to sham or cecal ligation and puncture surgery and treated with or without a TIMP-2-neutralizing antibody. Animals were followed for 48 h and then sacrificed for analysis of TIMP-2 expression, cell cycle, and histology. Anti-TIMP-2 resulted in decreased lumen TIMP-2 expression which markedly increased cell cycle progression and attenuated epithelial cell injury by histology. TIMP-2 mediates S-AKI and appears to be a viable drug target.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Collagenase from Clostridium histolyticum, for general use, Type I, ≥125 CDU/mg solid
Sigma-Aldrich
5-Bromo-2′-deoxyuridine, ≥99% (HPLC)
Sigma-Aldrich
Creatinine Assay Kit, sufficient for 100 colorimetric or fluorometric tests
Sigma-Aldrich
Deoxyribonuclease I from bovine pancreas, lyophilized powder, Protein ≥85 %, ≥400 Kunitz units/mg protein
Sigma-Aldrich
SphereCol®, Human Collagen Type I Coated Beads, for 3D bio-scaffold